Search Results - robert+bradley

1 Results

Sort By:

Immune Modulation of DUX4 in Cancer DUX4 as predictive biomarker and therapeutic target to enhance the effectiveness of immunotherapies Although immune checkpoint blockade therapies represent important treatments for cancer, most patients are non-responders or may relapse. The efficacy of these treatments relies on cytotoxic T-cell recognition...

Published: 4/11/2025 | Updated: 2/27/2020 | Inventor(s): Stephen Tapscott, Robert Bradley, Amy Campbell, Guo-Liang Chew

Keywords(s): Biomarker, Immuno Oncology, Target

Category(s): Diagnostic